Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Recipient ID:

Date of HCT for which this form is being completed: __ __ __ __ - __ __- __ __

HCT type

(check only one)

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Other product

Specify:

Donor/Cord Blood Unit Information Questions: 1 - 9

Specify non-NMDP donor1

Related donor

Non-NMDP unrelated donor

Non-NMDP cord blood unit (include related and autologous CBUs)

Non-NMDP unrelated donor ID:2 (not applicable for related donor)

Non-NMDP cord blood unit ID:3 (include related and autologous CBUs)

Date of birth

Known Unknown

4

(donor/infant)

Date of birth:5 __ __ __ __ - __ __- __ __ (donor/infant)

Age

Known Unknown

6

(donor/infant)

Age:7 (donor/infant) Months (use only if less than 1 year old)

years

Sex

male female

8

(donor/infant)

Who is being tested for IDMs?9

donor IDM (marrow or PBSC)

maternal IDM (cord blood)

cord blood unit IDM

Infectious Disease Marker (report final test results) Questions: 10 - 46

HBsAg: (hepatitis B surface antigen)

Reactive Non-reactive Not done

10

Date sample collected:11 __ __ __ __ - __ __- __ __

Anti HBc: (hepatitis B core antibody)

Reactive Non-reactive Not done

12

Date sample collected:13 __ __ __ __ - __ __- __ __

Anti-HCV: (hepatitis C antibody)

Reactive Non-reactive Not done

14

Date sample collected:15 __ __ __ __ - __ __- __ __

Anti-HTLV I / II

Reactive Non-reactive Not done

16

Date sample collected:17 __ __ __ __ - __ __- __ __

HIV-1 p24 antigen

Reactive Non-reactive Not done Not reported

18

Date sample collected:19 __ __ __ __ - __ __- __ __

Was FDA licensed NAT testing for HIV-1 / HCV performed?

yes no

20

HIV-1

Positive Negative Not reported

21

Date sample collected:22 __ __ __ __ - __ __- __ __

HCV

Positive Negative

23

Date sample collected:24 __ __ __ __ - __ __- __ __

Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses)

Reactive Non-reactive Not done Not reported

25

*Testing for both HIV antibodies is required.  This testing may be performed as separate tests or done using a combined assay.

Date sample collected:26 __ __ __ __ - __ __- __ __

STS

Reactive Non-reactive Not done

27

Date sample collected:28 __ __ __ __ - __ __- __ __

Anti-CMV: (IgG or Total)

Reactive Non-reactive Not done

29

Date sample collected:30 __ __ __ __ - __ __- __ __

WNV-NAT testing

Positive Negative Not done Not applicable

31

Date sample collected:32 __ __ __ __ - __ __- __ __

Chagas testing

Positive Negative Not Done

33

Date sample collected:34 __ __ __ __ - __ __- __ __

Anti-HSV (Herpes simplex virus antibody)

Positive Negative Not Done

35

Date sample collected:36 __ __ __ __ - __ __- __ __

Anti-EBV (Epstein-Barr virus antibody)

Positive Negative Inconclusive Not done

37

Date sample collected:38 __ __ __ __ - __ __- __ __

Anti-VZV (Varicella zoster virus antibody)

Positive Negative Not Done

39

Date sample collected:40 __ __ __ __ - __ __- __ __

Toxoplasmosis

Positive Negative Not Done

41

Date sample collected:42 __ __ __ __ - __ __- __ __

Other infectious disease marker

yes no

43

Other infectious disease marker (1) Questions: 44 - 46

Date sample collected:44 __ __ __ __ - __ __- __ __

Specify test and method:45

Specify test results:46

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

OMB No: 0915-0310

Expiration Date: 1/31/2020

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
number.  The OMB control number for this project is 0915-0310.  Public reporting burden for this collection of information is estimated to average 1.0 hours per response, including the
time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

Product type: (check only one)

Hepatitis B Virus (HBV)

Hepatitis C Virus (HCV)

Human T-Lymphotropic Virus

Human Immunodeficiency Virus (HIV)

Specify results:

Syphilis

Cytomegalovirus (CMV)

West Nile Virus (WNV)

Chagas

Herpes simplex virus (HSV)

Epstein-Barr virus (EBV)

Varicella zoster virus (VZV)

Toxoplasmosis

Other Infectious Disease Marker

Center: CRID: 

Form 2004 R4.0: Infectious Disease Markers

CIBMTR Form 2004 revision 4.0 last updated Monday, February 26, 2018
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 1 / 3



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Recipient ID:

Date of HCT for which this form is being completed: __ __ __ __ - __ __- __ __

HCT type

(check only one)

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Other product

Specify:

Donor/Cord Blood Unit Information Questions: 1 - 9

Specify non-NMDP donor1

Related donor

Non-NMDP unrelated donor

Non-NMDP cord blood unit (include related and autologous CBUs)

Non-NMDP unrelated donor ID:2 (not applicable for related donor)

Non-NMDP cord blood unit ID:3 (include related and autologous CBUs)

Date of birth

Known Unknown

4

(donor/infant)

Date of birth:5 __ __ __ __ - __ __- __ __ (donor/infant)

Age

Known Unknown

6

(donor/infant)

Age:7 (donor/infant) Months (use only if less than 1 year old)

years

Sex

male female

8

(donor/infant)

Who is being tested for IDMs?9

donor IDM (marrow or PBSC)

maternal IDM (cord blood)

cord blood unit IDM

Infectious Disease Marker (report final test results) Questions: 10 - 46

HBsAg: (hepatitis B surface antigen)

Reactive Non-reactive Not done

10

Date sample collected:11 __ __ __ __ - __ __- __ __

Anti HBc: (hepatitis B core antibody)

Reactive Non-reactive Not done

12

Date sample collected:13 __ __ __ __ - __ __- __ __

Anti-HCV: (hepatitis C antibody)

Reactive Non-reactive Not done

14

Date sample collected:15 __ __ __ __ - __ __- __ __

Anti-HTLV I / II

Reactive Non-reactive Not done

16

Date sample collected:17 __ __ __ __ - __ __- __ __

HIV-1 p24 antigen

Reactive Non-reactive Not done Not reported

18

Date sample collected:19 __ __ __ __ - __ __- __ __

Was FDA licensed NAT testing for HIV-1 / HCV performed?

yes no

20

HIV-1

Positive Negative Not reported

21

Date sample collected:22 __ __ __ __ - __ __- __ __

HCV

Positive Negative

23

Date sample collected:24 __ __ __ __ - __ __- __ __

Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses)

Reactive Non-reactive Not done Not reported

25

*Testing for both HIV antibodies is required.  This testing may be performed as separate tests or done using a combined assay.

Date sample collected:26 __ __ __ __ - __ __- __ __

STS

Reactive Non-reactive Not done

27

Date sample collected:28 __ __ __ __ - __ __- __ __

Anti-CMV: (IgG or Total)

Reactive Non-reactive Not done

29

Date sample collected:30 __ __ __ __ - __ __- __ __

WNV-NAT testing

Positive Negative Not done Not applicable

31

Date sample collected:32 __ __ __ __ - __ __- __ __

Chagas testing

Positive Negative Not Done

33

Date sample collected:34 __ __ __ __ - __ __- __ __

Anti-HSV (Herpes simplex virus antibody)

Positive Negative Not Done

35

Date sample collected:36 __ __ __ __ - __ __- __ __

Anti-EBV (Epstein-Barr virus antibody)

Positive Negative Inconclusive Not done

37

Date sample collected:38 __ __ __ __ - __ __- __ __

Anti-VZV (Varicella zoster virus antibody)

Positive Negative Not Done

39

Date sample collected:40 __ __ __ __ - __ __- __ __

Toxoplasmosis

Positive Negative Not Done

41

Date sample collected:42 __ __ __ __ - __ __- __ __

Other infectious disease marker

yes no

43

Other infectious disease marker (1) Questions: 44 - 46

Date sample collected:44 __ __ __ __ - __ __- __ __

Specify test and method:45

Specify test results:46

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

OMB No: 0915-0310

Expiration Date: 1/31/2020

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
number.  The OMB control number for this project is 0915-0310.  Public reporting burden for this collection of information is estimated to average 1.0 hours per response, including the
time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

Product type: (check only one)

Hepatitis B Virus (HBV)

Hepatitis C Virus (HCV)

Human T-Lymphotropic Virus

Human Immunodeficiency Virus (HIV)

Specify results:

Syphilis

Cytomegalovirus (CMV)

West Nile Virus (WNV)

Chagas

Herpes simplex virus (HSV)

Epstein-Barr virus (EBV)

Varicella zoster virus (VZV)

Toxoplasmosis

Other Infectious Disease Marker

Center: CRID: 

Form 2004 R4.0: Infectious Disease Markers

CIBMTR Form 2004 revision 4.0 last updated Monday, February 26, 2018
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 2 / 3



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Recipient ID:

Date of HCT for which this form is being completed: __ __ __ __ - __ __- __ __

HCT type

(check only one)

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Other product

Specify:

Donor/Cord Blood Unit Information Questions: 1 - 9

Specify non-NMDP donor1

Related donor

Non-NMDP unrelated donor

Non-NMDP cord blood unit (include related and autologous CBUs)

Non-NMDP unrelated donor ID:2 (not applicable for related donor)

Non-NMDP cord blood unit ID:3 (include related and autologous CBUs)

Date of birth

Known Unknown

4

(donor/infant)

Date of birth:5 __ __ __ __ - __ __- __ __ (donor/infant)

Age

Known Unknown

6

(donor/infant)

Age:7 (donor/infant) Months (use only if less than 1 year old)

years

Sex

male female

8

(donor/infant)

Who is being tested for IDMs?9

donor IDM (marrow or PBSC)

maternal IDM (cord blood)

cord blood unit IDM

Infectious Disease Marker (report final test results) Questions: 10 - 46

HBsAg: (hepatitis B surface antigen)

Reactive Non-reactive Not done

10

Date sample collected:11 __ __ __ __ - __ __- __ __

Anti HBc: (hepatitis B core antibody)

Reactive Non-reactive Not done

12

Date sample collected:13 __ __ __ __ - __ __- __ __

Anti-HCV: (hepatitis C antibody)

Reactive Non-reactive Not done

14

Date sample collected:15 __ __ __ __ - __ __- __ __

Anti-HTLV I / II

Reactive Non-reactive Not done

16

Date sample collected:17 __ __ __ __ - __ __- __ __

HIV-1 p24 antigen

Reactive Non-reactive Not done Not reported

18

Date sample collected:19 __ __ __ __ - __ __- __ __

Was FDA licensed NAT testing for HIV-1 / HCV performed?

yes no

20

HIV-1

Positive Negative Not reported

21

Date sample collected:22 __ __ __ __ - __ __- __ __

HCV

Positive Negative

23

Date sample collected:24 __ __ __ __ - __ __- __ __

Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses)

Reactive Non-reactive Not done Not reported

25

*Testing for both HIV antibodies is required.  This testing may be performed as separate tests or done using a combined assay.

Date sample collected:26 __ __ __ __ - __ __- __ __

STS

Reactive Non-reactive Not done

27

Date sample collected:28 __ __ __ __ - __ __- __ __

Anti-CMV: (IgG or Total)

Reactive Non-reactive Not done

29

Date sample collected:30 __ __ __ __ - __ __- __ __

WNV-NAT testing

Positive Negative Not done Not applicable

31

Date sample collected:32 __ __ __ __ - __ __- __ __

Chagas testing

Positive Negative Not Done

33

Date sample collected:34 __ __ __ __ - __ __- __ __

Anti-HSV (Herpes simplex virus antibody)

Positive Negative Not Done

35

Date sample collected:36 __ __ __ __ - __ __- __ __

Anti-EBV (Epstein-Barr virus antibody)

Positive Negative Inconclusive Not done

37

Date sample collected:38 __ __ __ __ - __ __- __ __

Anti-VZV (Varicella zoster virus antibody)

Positive Negative Not Done

39

Date sample collected:40 __ __ __ __ - __ __- __ __

Toxoplasmosis

Positive Negative Not Done

41

Date sample collected:42 __ __ __ __ - __ __- __ __

Other infectious disease marker

yes no

43

Other infectious disease marker (1) Questions: 44 - 46

Date sample collected:44 __ __ __ __ - __ __- __ __

Specify test and method:45

Specify test results:46

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

OMB No: 0915-0310

Expiration Date: 1/31/2020

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
number.  The OMB control number for this project is 0915-0310.  Public reporting burden for this collection of information is estimated to average 1.0 hours per response, including the
time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

Product type: (check only one)

Hepatitis B Virus (HBV)

Hepatitis C Virus (HCV)

Human T-Lymphotropic Virus

Human Immunodeficiency Virus (HIV)

Specify results:

Syphilis

Cytomegalovirus (CMV)

West Nile Virus (WNV)

Chagas

Herpes simplex virus (HSV)

Epstein-Barr virus (EBV)

Varicella zoster virus (VZV)

Toxoplasmosis

Other Infectious Disease Marker

Center: CRID: 

Form 2004 R4.0: Infectious Disease Markers

CIBMTR Form 2004 revision 4.0 last updated Monday, February 26, 2018
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 3 / 3